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(MT) in patients with emergent large ‑vessel oc‑
clusion (ELVO) who meet criteria for the inter‑
vention, irrespective of whether thrombolysis 
has been administered or not.1,2 The MT number 
needed to treat to significantly reduce disability 
is only 2.6.4 Presently, there is only one stroke 
MT center (comprehensive stroke center, CSC; 
defined by the guidelines as a center perform‑
ing a full range of interventional neuroradiolo‑
gy services, in most cases with on‑site neurosur‑
gery) listed to cover the MT needs in the country 
area of 3.4 million inhabitants (province; Polish: 
województwo). Transportation from the index 
hospital to the CSC lasts about 1.5 hours.
Cardiologist on call was requested to deter‑
mine whether the patient was fit for transporta‑
tion to the CSC. The patient had nonspecific ST ‑T 
wave changes on electrocardiogram (including 
a high‑rise J point), which were interpreted by 
the consulting cardiologist on call as most like‑
ly secondary to the ongoing stroke, not requir‑
ing any urgent coronary status evaluation. As 
the onsite MT was not allowed, the patient was 
cleared for an immediate transfer to the CSC for 
an emergent MT as a first‑line treatment.
The patient was first accepted for MT at the 
CSC and an immediate transport arrangement 
was triggered, but a few minutes later the CSC 
team decision was communicated to reject the pa‑
tient because of “the detrimental effect of trans‑
port time on the MT treatment window” (ditto).
Follow ‑up CT showed evolution of the MCA in‑
farct (FIGURE 1B). No acute coronary syndrome occurred. 
Two weeks later, the patient, severely disabled, 
was transferred to a stroke rehabilitation center.
On a Sunday night (9.40 PM), a 69‑year ‑old man 
with an up to 4‑hour history of left ‑sided hemi‑
paresis was brought by ambulance to the emer‑
gency department of a large regional hospital. 
The patient was last seen well by his son at 6.00 
PM, as he was walking to his room to take a nap. 
The patient woke up just before 9.00 PM and 
alarmed the family due to hemiparesis. They 
immediately called the emergency number 112. 
Emergency medical services came without delay, 
as the patient’s house is about 15 minutes drive 
away from the hospital.
The hospital to which the patient was ad‑
mitted provides stroke service to a  popula‑
tion of about 500 000 individuals and is one of 
the country leaders in stroke thrombolysis. Ten 
days before, the patient had undergone surgery 
for a trapped (incarcerated) hernia; otherwise, 
he had been active and well, with no known 
stroke risk factors.
The patient’s National Institute of Health 
Stroke Scale score was 21. Plain computed to‑
mography (CT) excluded intracranial bleed‑
ing and showed early infarct signs in the right 
middle cerebral artery (MCA) territory (FIGURE 1A). 
The Alberta Stroke Program Early CT Score 
(ASPECTS) was 8, suggesting salvageable ce‑
rebral tissue.1 Computed tomography angiog‑
raphy showed the occlusion of the M1 segment 
of the right MCA, with a rich collateral supply 
(FIGURE 1D–1F) and no other extra‑ or intracranial 
vessel pathology. Thrombolysis was not admin‑
istered due to the recent surgery.
Currently, there is level 1A (class IA) evidence 
for routine use of mechanical thrombectomy 
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particular, any long ‑term or extensive neuroin‑
terventional training.4
Establishing more thrombectomy ‑capable 
stroke centers (TCSCs; centers performing MTs 
in ELVO stroke; on‑site neurosurgery is not a re‑
quirement as per international guidelines and 
regulations in Poland; patients in need of other 
cerebral artery interventions, such as elective 
malformation or aneurysm treatment, or in‑
terventions in hemorrhagic stroke secondary 
prevention, are routinely referred from TCSCs 
to a CSC) reduces patients’ disability, is cost‑
‑effective, and can save lives.4,5 However, it re‑
mains a fundamentally unfinished job, present‑
ly resulting in a continued systemic production 
of preventable invalids5 (FIGURE 1).
Following multispecialty consultations, TCSC 
and noninterventional radiologist operator re‑
quirements have been recently agreed on and set 
in Poland (see reference 16 in the additional refer‑
ence list [Supplementary material]). Requirements 
Strokes should, whenever possible, be pre‑
vented rather than experienced.2,3 Eighty percent 
of strokes do not show any warning symptoms.2,3
Acute ischemic ELVO stroke should be treat‑
ed in a timely and effective fashion, in line with 
the current medical knowledge and as mandat‑
ed by the guidelines.2,4 Any delay in MT re‑
perfusion is associated with significantly in‑
creased patients’ disability and limited func‑
tional independence.2,4
The shortage of MT ‑capable centers and op‑
erators is the key factor limiting the access to 
and delivery of MT in patients with ELVO stroke 
(Aguiar de Sousa et al, see the additional refer‑
ence list [Supplementary material]). Evidence 
from the United States and Europe clearly shows 
that interventional cardiologists can safely per‑
form MT in cardiac catheterization laboratories, 
demonstrating results similar to those in neu‑
rointerventional centers without, for operators 
experienced in carotid artery stenting (CAS) in 
 FIGURE 1 Cerebral infarct in a patient with untreated emergent large ‑vessel occlusion (ELVO) acute ischemic stroke. Panels A, B, and C show infarct evolution in 
the absence of level 1A (class IA) international guideline‑mandated1 management by mechanical thrombectomy: A – axial plain computed tomography (CT) at baseline 
(up to 4 hours after ELVO onset); only mild early signs of infarction with effacement of the sulci (orange arrows) and mild cortical hypodensity (ASPECTS score 8); 
B, C – axial, nonenhanced CT at 2 weeks (B) and 3 months (C), showing the demarked infarcted area (red arrows); D, E – CT angiography at the time of presentation 
(at the same time ‑point as in A), showing the occlusion of the right distal M1 segment of the  middle cerebral artery (yellow arrow) and very good collateral supply 
(green arrows; Tan score 3) in coronal (D) and axial (E) planes. Collaterals play an important role in cerebral tissue salvage, influencing favorably the penumbra to core 
ratio. Evidence supports the role of collateral assessment in identifying patients likely to benefit from mechanical thrombectomy;1 F – a 3‑dimensional reconstruction 
of the baseline CT angiography with the occlusion of the M1 segment of the right middle cerebral artery (yellow arrow, coronal view) and a rich collateral supply 
(green arrows). Note that thrombolytic therapy (which was not implemented in this patient due to a recent major surgery) is much less effective than MT with 
or without intravenous thrombolysis.1 With MT, for every 100 patients treated, 22 additional patients reach independence (modified Rankin score, 0–2) at 3 months 
and 33 more patients achieve early neurological recovery (Saposnik et al, see the additional reference list [Supplementary material]).
A B C
ED F
KARDIOLOGIA POLSKA 2020; 78 (4)356
be, again and again, reiterated that cardiologists 
are 100% aware that MT is not a thrombectomy‑
‑involving primary percutaneous coronary in‑
tervention5 and that the cerebral artery is not 
a coronary artery,5 those challenges reflect, in 
essence, the history of primary percutaneous 
coronary intervention implementation chal‑
lenges in acute myocardial infarction.4,5 One 
key difference is that, for the brain, the time 
means far more than for the heart.4,5
All in all, stroke is not a primary disease 
of the neuron but a  v a s c u l a r  disease that 
requires, with ELVO, u r g e n t  v a s c u l a r 
management. 
SUPPLEMENTARY MATERIAL
Supplementary material is available at www.mp.pl/kardiologiapolska.
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for MT operators specialized in neurology, cardi‑
ology, angiology, or endovascular surgery include 
participation in at least 150 carotid or intracrani‑
al artery interventions and performing at least 50 
procedures of this kind as the first operator, 5 of 
which have to be intracranial artery interventions 
(proctorship accepted).
In 2019, to address the unmet need in the re‑
gion, the local hospital director set a multispe‑
cialty task force (involving specialists in car‑
diology, neurology, angiology, and anesthesia) 
to expand interventional cardiology services 
to in ‑house endovascular procedures focused 
on the cephalic arteries. Carotid artery stent‑
ing procedures are now regularly performed lo‑
cally, for both symptomatic and asymptomatic 
patients at increased risk of developing stroke, 
who live in the region.
After more than 2 months of institutional 
neurorehabilitation, the patient reached a mod‑
ified Rankin score of 4, necessitating help for 
most aspects of daily living, including using 
the toilet. It is highly unlikely that he will ever 
return to work (that is, part ‑time work, as 
the patient was retired). Rather, he will require 
external care to the end of his life. As per dis‑
charge summary, his family members were in‑
dicated as future caregivers.
The number of stroke patients who should, but 
do not (for a variety of reasons), receive MT can 
be calculated by subtracting the number of MTs 
performed from the number of patients requir‑
ing MT. The annual incidence of ELVO is 24 to 31 
cases per 100 000 people. Currently, at least 10% 
of stroke admissions require MT, and the pro‑
portion is expected to rise with increasing public 
awareness and improved referral pathways.2,4,5 
According to the raw data of the Polish Nation‑
al Health Fund (Polish: Narodowy Fundusz 
Zdrowia [NFZ]), only 1111 MTs were performed 
in Poland, a country of 38 million inhabitants, 
between January and November 2019.
Fundamental challenges of delivering 
the guideline ‑indicated1 stroke treatment in 
MT ‑eligible patients include improvements in 
immediate symptom recognition and referral 
(public awareness),2,5 improved identification 
of patients who need to (and should) be treated 
beyond the 6‑hour window,1,2 increased number 
of centers and operators capable of performing 
MT on a true rather than theoretical 24/7/365 
basis (establishing more TCSCs, as indicated in‑
ternationally,1,4,5 to complement sparsely locat‑
ed CSCs, lifting MT training barriers imposed 
on MT operators from neurology and vascu‑
lar specialties), multispecialty collaboration to 
serve patients and not the ill‑perceived “terri‑
torial” issues4 and improvements in patient lo‑
gistics including reducing delays and minimiz‑
ing the negative effect of unnecessary trans‑
portation (in particular, regarding between‑
‑hospital transportations). Whereas it needs to 
